Claret Capital Partners invests €28M in Cinclus Pharma Cinclus Pharma is a late-stage clinical pharmaceutical company ...

Pharmaceutical and biotech companies have seen a shrinking share of investments across the five boroughs in the first half of 2025 as software startups suck up more of the city’s venture capital. More ...

The biotech industry’s challenging years might finally be giving way to more optimism as a new funding wave takes shape.

R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class ...

Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the sole purpose of developing novel therapies in tandem with the Shanghai-based ...

Milan-based Alomana has raised €4M led by CDP Venture Capital for Alo, its AI operating layer for autonomous enterprise ...

Crunchbase data shows global venture investment totaled $189 billion in February — the largest startup funding month on ...

Other investors, including We Founder Circle, Alkemi Growth Capital and Alpha Capital, have also exited the company, Venture ...

Cinclus Pharma is a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases -- Claret Capital Partners providing growth funding of up to ...